3D Single Use Bag Market Outlook

The global 3D single-use bag market size was valued at USD 1.5 billion in 2023 and is projected to reach USD 4.3 billion by 2032, growing at a CAGR of 12.5% during the forecast period. This robust growth can be attributed to the increasing adoption of single-use technologies in biopharmaceutical manufacturing, coupled with the rising demand for flexible and efficient solutions in laboratories and other scientific applications.

A key growth factor driving the 3D single-use bag market is the rapid expansion of the biopharmaceutical industry. With the growing prevalence of chronic diseases and an aging population, there is an increasing need for advanced therapeutic products. This has led to significant investments in biopharmaceutical research and development, which in turn has spurred demand for single-use technologies that offer greater flexibility, reduced risk of contamination, and lower production costs. 3D single-use bags are particularly advantageous in this context as they can be customized to meet specific process requirements, facilitating more efficient and scalable production processes.

In addition to the biopharmaceutical sector, the laboratory and research environments are also contributing to the market growth. Laboratories, both academic and industrial, are increasingly adopting single-use systems to streamline operations and improve efficiency. These systems are especially beneficial for high-throughput screening, cell culture, and other applications that require sterile and reliable containment solutions. The versatility and ease of use of 3D single-use bags make them an attractive option for a wide range of laboratory applications, further driving market expansion.

The food and beverage industry is another sector where 3D single-use bags are gaining traction. As consumer demand for high-quality, safe, and sustainable products grows, manufacturers are seeking innovative packaging solutions that ensure product integrity and extend shelf life. 3D single-use bags offer excellent barrier properties and can be used for aseptic processing, making them ideal for preserving the quality and safety of food and beverage products. This adoption is expected to augment market growth significantly over the forecast period.

Single-Use Technologies for the Biologic sector are revolutionizing the way biopharmaceuticals are manufactured. These technologies provide a flexible and cost-effective alternative to traditional stainless-steel systems, significantly reducing the risk of contamination and the need for extensive cleaning and validation processes. The integration of single-use technologies in biologic production allows for faster turnaround times and increased efficiency, which is crucial in meeting the growing demand for biologics and personalized therapies. As the biopharmaceutical industry continues to evolve, the adoption of single-use technologies is expected to accelerate, offering manufacturers the ability to quickly adapt to changing market needs and regulatory requirements.

From a regional perspective, North America holds a significant share of the 3D single-use bag market, driven by the presence of a large number of biopharmaceutical companies and advanced research facilities. Europe follows closely, with substantial investments in biotechnology and a strong regulatory framework supporting single-use technologies. The Asia Pacific region is anticipated to witness the highest growth rate, attributed to the rapid expansion of the biopharmaceutical industry and increasing investments in research and development. Emerging economies in Latin America and the Middle East & Africa are also expected to contribute to market growth, albeit at a slower pace, as they gradually adopt advanced bioprocessing technologies.

Product Type Analysis

The product type segment of the 3D single-use bag market is divided into standard 3D bags and customized 3D bags. Standard 3D bags are pre-designed to meet common requirements and are widely used due to their cost-effectiveness and availability. These bags are typically employed in processes where the production parameters are well-defined and do not require specific customization. The ease of procurement and immediate availability of standard 3D bags make them a popular choice among biopharmaceutical manufacturers and labor

OGC i3s 3D Object Scene layer of the 3D BAG for the city of Dordrecht from the 3D BAG by 3D geoinformation research group, TU Delft. For more information on the BAG 3D copyright, please check this copyright page.

Latest (near-live) version of the BAG data. Parent item: 3D Registration of Buildings and Addresses (BAG) The 3D BAG is a register of addresses and buildings of the Netherlands, including building height information and related quality metrics. The data set is updated every month, keeping it up-to-date with the latest building stock and elevation information. The 3D BAG is generated from two data sources, the Dutch national register of addresses and buildings (Basisregistraties Adressen en Gebouwen (BAG)) and the national elevation model (AHN).

The disposable 3D liquid storage bag market is projected to reach USD 1,284.4 million by 2033, exhibiting a CAGR of 9.6% during the forecast period. The growth of the market is attributed to the rising demand for biopharmaceuticals, the increasing prevalence of cell therapy, and the growing adoption of single-use technologies in the pharmaceutical industry. The market is also driven by the technological advancements in 3D cell culture and bioprinting techniques. However, the high cost of 3D liquid storage bags and the risk of contamination may restrain the market growth to some extent. North America accounted for the largest share of the disposable 3D liquid storage bag market in 2022. The region is home to leading biopharmaceutical and cell therapy companies. Europe is expected to be the second-largest market, followed by Asia Pacific. The increasing demand for biopharmaceuticals and the rising adoption of single-use technologies in these regions are driving the market growth.

Crew lock bag. Polygons: 405 Vertices: 514

3D Bioprocess Bags Market size was valued at USD 4.68 Billion in 2023 and is projected to reach USD 14.09 Billion by 2030, growing at a CAGR of 17.3% during the forecast period 2024-2030.Global 3D Bioprocess Bags Market DriversThe market drivers for the 3D Bioprocess Bags Market can be influenced by various factors. These may include:Increasing Biopharmaceutical Production: As a result of the development of biologics and biosimilars, the biopharmaceutical industry has experienced rapid expansion. This growth may result in an increase in demand for 3D bioprocess bags, which are widely utilized in the manufacturing and storage of biopharmaceuticals.Developments in Cell Culture Technologies: The market for 3D bioprocess bags may expand as a result of the use of 3D cell culture systems for a range of purposes, including tissue engineering and drug discovery.Emphasis on Single-Use technology: The market for 3D bioprocess bags is anticipated to gain from the bioprocessing industry's move toward single-use technology. In bioprocessing activities, single-use solutions provide cost-effectiveness, less hazards of cross-contamination, and enhanced flexibility.Growing Need for customized Medicine: Since 3D bioprocess bags are essential to the creation of cell-based treatments and tissue engineering applications, the growing focus on customized medicine and regenerative therapies may fuel the market for these materials.Strict Regulations: 3D bioprocess bags, which have benefits in terms of lowering contamination risks, may be used as a result of regulatory agencies stressing the necessity for biopharmaceutical firms to adhere to quality and safety requirements.Expanding Biotechnology Industry: The market for 3D bioprocess bags may rise as a result of the biotechnology industry's general growth, which includes R&D initiatives.Worldwide Pandemic Readiness: The COVID-19 outbreak has shown the significance of adaptable and expandable bioprocessing approaches. The way the industry responds to global health issues may influence investments and advances in 3D bioprocess bags, among other technologies.Environmental Sustainability: Since single-use bioprocess bags are disposable, businesses aiming to cut back on waste production and water consumption in comparison to conventional stainless-steel bioreactors may find them appealing as the industry grows more ecologically aware.

The global 3D single-use bag market is experiencing robust growth, driven by increasing demand from the pharmaceutical and biotechnology sectors. The market's expansion is fueled by the advantages of single-use systems, including reduced contamination risks, faster turnaround times, and lower overall costs compared to traditional reusable systems. Technological advancements in 3D printing are enabling the creation of highly customized and efficient single-use bags, catering to the specific needs of various applications. Furthermore, the rising prevalence of biopharmaceutical manufacturing and the growing adoption of continuous manufacturing processes are significantly boosting market demand. We estimate the 2025 market size to be $1.5 billion, with a Compound Annual Growth Rate (CAGR) of 12% projected from 2025 to 2033. This strong growth trajectory is expected to continue, driven by factors such as increased investment in research and development, expansion into emerging markets, and the ongoing need for enhanced sterility and efficiency in biopharmaceutical manufacturing. The market segmentation reveals a significant portion of the demand stems from the 101-500L and 501-1500L bag categories, indicating a preference for larger capacity bags in high-throughput manufacturing settings. Geographically, North America and Europe currently hold a substantial market share, attributed to the presence of major pharmaceutical companies and established regulatory frameworks. However, rapid growth is anticipated in the Asia-Pacific region, fueled by increasing pharmaceutical manufacturing capabilities and investments in advanced biotechnology infrastructure in countries like China and India. While the market faces challenges such as regulatory complexities and the potential for material limitations, the overall outlook remains positive, with continued innovation and market expansion expected in the coming years. Key players like Corning Incorporated, Entegris, and Thermo Fisher Scientific are actively shaping market dynamics through strategic partnerships, product development, and expansion initiatives.

The 3D Single-Use bag market is experiencing robust growth, driven by increasing demand in biopharmaceutical manufacturing and a shift towards single-use technologies. This market is projected to reach a value of $1.5 billion by 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 12% from 2025 to 2033. This significant expansion is fueled by several key factors. Firstly, the advantages of single-use systems, including reduced cleaning and sterilization costs, faster turnaround times, and minimized contamination risks, are increasingly attractive to manufacturers seeking efficiency and cost-effectiveness. Secondly, the growing adoption of continuous processing in biomanufacturing, a method particularly well-suited for single-use systems like 3D bags, is another significant driver. Finally, the rising prevalence of chronic diseases and the resultant surge in biopharmaceutical production are further contributing to market expansion. Leading companies like Corning Incorporated, Entegris, and Thermo Fisher Scientific are actively shaping market dynamics through innovation and strategic partnerships. The market segmentation within 3D Single-Use bags includes various sizes and materials catering to specific process requirements. Geographic distribution sees robust growth across North America and Europe, driven by strong regulatory frameworks and a high concentration of biopharmaceutical companies. However, emerging economies in Asia-Pacific are exhibiting rapid growth potential due to increasing investment in healthcare infrastructure and rising biopharmaceutical manufacturing capabilities. While the market faces some challenges, such as the relatively higher initial investment costs associated with single-use systems and concerns regarding material compatibility, the overall trend is overwhelmingly positive, indicating a sustained trajectory of growth over the forecast period. This continued expansion presents compelling opportunities for market players to innovate and capitalize on the benefits offered by this rapidly evolving technology. This comprehensive report provides a detailed analysis of the burgeoning 3D single-use bag market, projecting a market value exceeding $5 billion by 2030. The report delves into key market segments, competitive landscapes, emerging trends, and growth drivers, offering valuable insights for industry stakeholders. This in-depth study utilizes rigorous market research methodologies and leverages data from reputable sources to present a clear and actionable understanding of this dynamic sector.

Report of Medical 3D Liquid Storage Bag is covering the summarized study of several factors encouraging the growth of the market such as market size, market type, major regions and end user applications. By using the report customer can recognize the several drivers that impact and govern the market. The report is describing the several types of Medical 3D Liquid Storage Bag Industry. Factors that are playing the major role for growth of specific type of product category and factors that are motivating the status of the market.

The global medical 3D liquid storage bag market size is projected to grow from an estimated USD 1.5 billion in 2025 to USD 2.5 billion by 2033, at a CAGR of 6.5%. The market growth is attributed to increasing demand for advanced and efficient liquid storage solutions in medical institutions and laboratories. These bags offer numerous advantages, such as biocompatibility, leak resistance, and high-capacity storage. The growing prevalence of chronic diseases and surgical procedures further drives the demand for secure and reliable storage of medical fluids, including blood, plasma, and reagents. The market is segmented into various application areas, including medical institutions, laboratories, and others. Medical institutions hold significant market share due to the extensive use of liquid storage bags for storing blood components, sterile fluids, and pharmaceuticals. The laboratory segment is also expected to witness substantial growth due to the increasing need for liquid storage solutions in research and development activities. Key market players include Sartorius AG, Terumo Corporation, Bioneau, Amcor, and Romynox. The competitive landscape is characterized by strategic partnerships, mergers, and acquisitions to expand product portfolios and gain market share.

Actualiteit: 20 april 2024 (2024.12.06 - beta)Deze laag bevat de BAG-gebouwen in 3D in Nederland. De dataset is gebaseerd op de 3D BAG data van tudelft3d en 3DGI. Deze dataset is gebaseerd op de Basisregistratie Adressen en Gebouwen (BAG) en het Actueel Hoogtebestand Nederland (AHN3, 4 en 5). Meer informatie over deze dataset kunt u hier terugvinden. In de Release Notes is specifiekere informatie over deze release terug te vinden. De kaart toont de gebouwen naar status en de features zijn LOD 2.2Deze kaartlaag maakt onderdeel uit van een uitgebreide collectie van 3D-kaarten die gebruikt kunnen worden als basis voor uw eigen 3D-informatieproducten. Het is mogelijk om deze laag toe te voegen in een scene in ArcGIS Pro, in de ArcGIS Online-scene viewer en in ArcGIS Earth. Vervolgens kunt u eigen informatie aan de kaart toevoegen en als scene opslaan in ArcGIS Online. Naast deze scene layer heeft Esri Nederland een web scene beschikbaar gesteld. Een eenzelfde scene layer is ook beschikbaar in WGS. Een overzicht alle beschikbaar 3D Content is te vinden in de groep 3D. Deze laag is aangeboden vanuit Esri Nederland Content. Esri Nederland Content biedt landsdekkende data en services aan die gebruikt kunnen worden in het ArcGIS platform. Het content-team actualiseert het aanbod en voegt geregeld nieuwe content toe. Door content van Esri Nederland te combineren met andere gegevens creëert u snel en eenvoudig nieuwe informatieproducten. Meer informatie over het content aanbod is te vinden via: esri.nl/content. Heeft u vragen of opmerkingen dan horen wij dat graag via content@esri.nl. Blijf op de hoogte van het laatste content-nieuws via de Esri Nederland Content Hub.

Oversize Bag 3D Scanner Market Outlook

According to our latest research, the global Oversize Bag 3D Scanner market size reached USD 1.29 billion in 2024, reflecting robust adoption across key sectors. The market is expected to grow at a CAGR of 12.1% from 2025 to 2033, and is projected to achieve a value of USD 3.62 billion by 2033. This notable expansion is driven primarily by increasing security requirements, automation in logistics, and the need for efficient, precise scanning of oversized baggage and cargo across transportation and industrial environments. As per our comprehensive analysis, technological advancements and the integration of AI-driven analytics are further propelling the growth trajectory of the Oversize Bag 3D Scanner market.

One of the most significant growth factors for the Oversize Bag 3D Scanner market is the heightened emphasis on security and compliance in transportation hubs, especially airports and border checkpoints. With global passenger and cargo volumes steadily rising, regulatory authorities are demanding more accurate, non-intrusive, and rapid scanning solutions to enhance screening throughput and minimize bottlenecks. The deployment of 3D scanners for oversized baggage enables operators to identify threats, contraband, or prohibited items with higher precision and speed compared to conventional X-ray systems. This security-driven adoption is further supported by government mandates and international aviation safety standards, which are fueling investments in advanced scanning technologies.

Another major driver is the rapid digital transformation sweeping across logistics and warehousing. The rise of e-commerce and globalized supply chains has amplified the need for real-time, automated tracking and inspection of large parcels and cargo. Oversize Bag 3D Scanners offer unparalleled advantages in terms of accuracy, efficiency, and scalability. By facilitating automated dimensioning, volumetric analysis, and defect detection, these systems help logistics providers optimize space utilization, reduce manual handling errors, and accelerate throughput. The integration of 3D scanning with warehouse management systems and robotics further enhances operational productivity, making it a key enabler for digital logistics ecosystems.

Technological innovation is also catalyzing market expansion. The convergence of laser scanning, structured light, and photogrammetry technologies is yielding scanners with higher resolution, faster processing speeds, and improved portability. The adoption of AI and machine learning algorithms in 3D scanners is enabling automated anomaly detection, predictive maintenance, and adaptive scanning, thereby reducing operational costs and human intervention. Moreover, the growing availability of portable and handheld 3D scanners is democratizing access to advanced scanning capabilities across small and medium enterprises, further broadening the market base.

From a regional perspective, North America and Europe are currently the largest markets, driven by stringent security regulations, high adoption rates in aviation and logistics, and strong technology infrastructure. However, the Asia Pacific region is witnessing the fastest growth, fueled by expanding air travel, booming e-commerce, and massive investments in airport and logistics infrastructure. Latin America and the Middle East & Africa are also emerging as promising markets, supported by modernization initiatives in transportation and customs operations. The global landscape thus reflects a balanced mix of mature markets and high-growth emerging regions, creating diverse opportunities for market players.

Product Type Analysis

The Oversize Bag 3D Scanner market is segmented by product type into Handheld 3D Scanners, Stationary 3D Scanners, and Portable 3D Scanners. Handheld 3D scanners have gained significant traction due to their flexibility and ease of use. These devices are particularly favored in environments where mobility is crucial, such as on-site inspecti

De 3D BAG is een actuele dataset met daarin de 3D-gebouwen van Nederland. De 3D BAG is open data. Het bevat 3D-modellen die worden gegenereerd door twee open datasets te combineren: de gebouwgegevens uit de BAG en de hoogtegegevens uit de AHN. De 3D BAG wordt regelmatig bijgewerkt, zodat deze up-to-date blijft met de nieuwste vrij beschikbare gebouwenvoorraad en hoogte-informatie.

The global disposable 2D/3D liquid storage bag market is experiencing robust growth, driven by the increasing demand for single-use systems in the biopharmaceutical and healthcare industries. The shift towards sterile, contamination-free solutions, coupled with the rising prevalence of chronic diseases necessitating large-scale biopharmaceutical production, fuels this expansion. Technological advancements, such as improved material science leading to enhanced barrier properties and increased flexibility in bag design (2D vs 3D), further contribute to market growth. This trend is particularly evident in the aseptic processing and cell culture applications within biomanufacturing, where single-use systems offer significant advantages in terms of efficiency, cost-effectiveness, and reduced risk of cross-contamination. The market is segmented by bag type (2D, 3D), material (polymers like polyethylene and polypropylene), capacity, and end-user (pharmaceutical, biotechnology). While precise market sizing data is unavailable, a reasonable estimate based on similar single-use technologies and industry growth trends would suggest a market size in the range of $1.5-2 billion in 2025, with a compound annual growth rate (CAGR) of approximately 8-10% through 2033. This growth is not without challenges. Regulatory compliance and stringent quality standards pose significant hurdles for manufacturers. Moreover, fluctuations in raw material prices and the potential for substitute technologies, such as advanced reusable systems, could impact market dynamics. However, the sustained demand from the burgeoning biopharmaceutical sector and ongoing technological innovation in bag design and material science are expected to overcome these challenges. Key players such as Sartorius, Terumo, and Cytiva are strategically positioning themselves to benefit from this growth by investing in research and development, expanding their product portfolios, and focusing on geographical expansion, particularly in emerging markets with rapidly growing biopharmaceutical industries. The competitive landscape is also characterized by both established multinational companies and smaller, specialized manufacturers focusing on niche applications.

The global medical 3D storage bag market is experiencing robust growth, driven by the increasing demand for efficient and safe storage solutions within the healthcare and research sectors. This surge is fueled by the rising prevalence of chronic diseases, the expanding research and development activities in pharmaceuticals and biotechnology, and the growing adoption of advanced 3D printing technologies for personalized medicine. The market is segmented by capacity (50L, 500L, 1000L, and others) and application (hospital, research, and others). Considering the significant investments in healthcare infrastructure globally and the continuous innovation in medical storage solutions, we estimate the market size in 2025 to be approximately $500 million. This figure is a reasonable projection based on the reported market size for related medical storage products and the projected growth rates of the overall medical device market. We project a Compound Annual Growth Rate (CAGR) of 8% from 2025 to 2033, leading to significant market expansion over the forecast period. Several factors are contributing to the market's expansion. The advantages of 3D storage bags, such as improved sterility, customizable designs for specific medical applications, and enhanced durability, are attracting significant interest from healthcare providers and research institutions. Technological advancements focusing on improved material science, resulting in bags with better barrier properties and resistance to degradation, are also key drivers. However, the market faces challenges such as stringent regulatory requirements, high initial investment costs for 3D printing technology, and potential concerns regarding the long-term biocompatibility of some materials used in 3D printed storage bags. Nevertheless, the overall market outlook remains positive, indicating substantial growth opportunities for manufacturers and suppliers involved in the production and distribution of medical 3D storage bags across diverse geographical regions.

Learn more about Market Research Intellect's Medical 3D Storage Bag Market Report, valued at USD 1.2 billion in 2024, and set to grow to USD 2.5 billion by 2033 with a CAGR of 9.0% (2026-2033).

Snapshot of the BAG data at 2020-05-13. Parent item: 3D Registration of Buildings and Addresses (BAG) The 3D BAG is a register of addresses and buildings of the Netherlands, including building height information and related quality metrics. The data set is updated every month, keeping it up-to-date with the latest building stock and elevation information. The 3D BAG is generated from two data sources, the Dutch national register of addresses and buildings (Basisregistraties Adressen en Gebouwen (BAG)) and the national elevation model (AHN).

Technological advancements in the 2D and 3D Single Use Bioprocess Bags industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transforming industry practices, offering a comprehensive outlook on future opportunities and market potential.

The global 3D bioprocess bag market is projected to reach $1,171.4 million by 2033, expanding at a CAGR of 2.8% from 2025 to 2033. Growing demand for biopharmaceuticals, advancements in bioprocessing technologies, and increasing investment in research and development activities drive the market. The increasing adoption of single-use systems in the biopharmaceutical industry, favorable government initiatives, and rising healthcare expenditure contribute to market growth. Key market participants include Thermo Fisher, Sartorius, Entegris, Labotec, KIEFEL GmbH, Merck, Meissner, ALLpaQ, Shandong Wongilin Medical Technology, Saint-Gobain Biopharm, ESI Ultrapure, Aseptic Group, and CellBios. These companies focus on product innovation, strategic partnerships, and geographic expansion to gain a competitive advantage. Regional analysis indicates that North America holds a significant market share due to the presence of leading biopharmaceutical companies and advanced healthcare infrastructure. Asia Pacific is expected to witness substantial growth owing to the increasing demand for biopharmaceuticals and government support for the biotechnology industry. Europe remains a key market due to the presence of established biopharmaceutical hubs, while the Middle East and Africa and South America offer growth opportunities due to rising healthcare spending and government initiatives.

The 3D bioprocess bag market is experiencing robust growth, driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing. This shift is fueled by several factors: reduced contamination risks, improved process efficiency, lower capital expenditure compared to traditional stainless steel systems, and the enhanced flexibility offered by single-use systems for handling diverse product types and batch sizes. The market is segmented by capacity (small, medium, high) and application (biopharmaceutical companies, life science R&D). While precise market sizing data is unavailable, industry reports suggest a substantial market value, likely exceeding $1 billion in 2025, with a compound annual growth rate (CAGR) exceeding 10% through 2033. This growth is projected across all segments, with high-capacity bags experiencing particularly strong demand due to the scale-up of biopharmaceutical production. North America and Europe currently dominate the market, but the Asia-Pacific region, particularly China and India, is expected to witness significant growth fueled by expanding biopharmaceutical manufacturing facilities and increasing government investments in life sciences R&D. However, challenges remain, including the relatively high cost of 3D bioprocess bags compared to traditional systems and potential regulatory hurdles related to single-use technologies. Major players like Thermo Fisher, Sartorius, and Entegris are actively shaping the market through innovation in bag design, material science, and integrated solutions. The competitive landscape is characterized by both established players and emerging companies, fostering innovation and driving price competitiveness. Future market trends point towards increased demand for customized bag designs, enhanced material compatibility for diverse biologics, and integration with advanced process analytical technologies (PAT) for real-time process monitoring and control. This focus on improved efficiency, quality, and regulatory compliance will drive the continued expansion of the 3D bioprocess bag market. The development and adoption of sustainable materials and processes are also emerging as significant trends to address growing environmental concerns in the industry.